Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 17/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 16/05 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 25.1M 22.05M 20.31M 18.99M 35.62M 2.37B 36.28M 244M 94.4M 1.17B 94.26M 92.19M 4.06B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.98M 24.57M 22.64M 21.17M 39.7M 2.64B 40.43M 272M 105M 1.3B 105M 103M 4.52B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.64% | +8.61% | +22.29% | -3.46% | 188B | ||
| +1.51% | +0.81% | -23.95% | +24.93% | 142B | ||
| +0.22% | +8.87% | -3.70% | -18.45% | 137B | ||
| +1.44% | +1.45% | -56.99% | -15.93% | 65.7B | ||
| +2.08% | +6.18% | +18.20% | +1.90% | 51.66B | ||
| -0.52% | -0.03% | -26.94% | -32.29% | 43.7B | ||
| +0.24% | +7.51% | +13.88% | +14.89% | 38.27B | ||
| -1.40% | +4.09% | +5.07% | +43.56% | 37.01B | ||
| +1.04% | +8.44% | -12.16% | -15.48% | 29.54B | ||
| Average | +0.42% | +2.98% | -7.15% | -0.04% | 81.35B | |
| Weighted average by Cap. | +0.36% | +3.25% | -4.55% | -0.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.15K 5.67K 5.3K 9.93K 661K 10.12K 67.97K 26.33K 326K 26.29K 25.71K 1.13M | 767K 674K 621K 580K 1.09M 72.37M 1.11M 7.45M 2.88M 35.68M 2.88M 2.82M 124M |
| Net income | -2.42M -2.12M -1.96M -1.83M -3.43M -228M -3.49M -23.47M -9.09M -112M -9.08M -8.88M -391M | -3.2M -2.81M -2.59M -2.42M -4.54M -302M -4.62M -31.03M -12.02M -149M -12M -11.74M -517M |
| Net Debt | 1.77M 1.56M 1.43M 1.34M 2.51M 167M 2.56M 17.2M 6.66M 82.38M 6.65M 6.5M 286M | 2.88M 2.53M 2.33M 2.18M 4.08M 271M 4.16M 27.93M 10.82M 134M 10.8M 10.56M 465M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















